David Roman - Jul 25, 2022 Form 4 Insider Report for Acutus Medical, Inc. (AFIB)

Role: President & CEO, Director
Signature: /s/ Tom Sohn as attorney-in-fact for David Roman
Stock symbol: AFIB
Transactions as of: Jul 25, 2022
Transactions value $: $0
Form type: 4
Date filed: 8/1/2022, 06:07 PM
Previous filing: Jun 2, 2022
Next filing: Feb 2, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AFIB	Common Stock	Award	$0	+75K	+40.9%	$0.00	258K	Aug 1, 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AFIB	Employee Stock Options (Right to Buy)	Disposed to Issuer		-77.3K	-60.73%		50K	Jul 25, 2022	Common Stock	77.3K	$13.66	Direct	F2
transaction	AFIB	Employee Stock Options (Right to Buy)	Award		+77.3K	+154.67%		127K	Jul 25, 2022	Common Stock	77.3K	$1.34	Direct	F2
transaction	AFIB	Employee Stock Options (Right to Buy)	Disposed to Issuer		-50K	-39.27%		77.3K	Jul 25, 2022	Common Stock	50K	$2.41	Direct	F3
transaction	AFIB	Employee Stock Options (Right to Buy)	Award		+50K	+64.65%		127K	Jul 25, 2022	Common Stock	50K	$1.34	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents restricted stock units that vest in four equal installments on each of the first four anniversaries of the vesting commencement date, subject to continued service through each such vesting date.
F2	The two reported transactions involved an amendment of an outstanding option reducing the exercise price of the option. The option was originally granted on April 1, 2021, with 1/4 vesting on the first anniversary of the vesting commencement date, and the remainder vesting in 36 equal monthly installments.
F3	The two reported transactions involved an amendment of an outstanding option reducing the exercise price of the option. The option was originally granted on February 1, 2022, with 1/2 vesting on the first anniversary of the vesting commencement date, and the remainder vesting in 12 equal monthly installments.